Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges. | Lung Cancer (Auckl) | 2021 | 34295201 | PubTator, text mining | PubMed |
| Mosaic Pattern of H3 K27M-Mutant Protein Expression in a Diffuse Midline Glioma-A Diagnostic Dilemma for the Pathologist. | J Neurosci Rural Pract | 2021 | 34295118 | PubTator, text mining | PubMed |
| Heterotopic ossification in mice overexpressing Bmp2 in Tie2+ lineages. | Cell Death Dis | 2021 | 34294700 | PubTator, text mining | PubMed |
| The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis. | Orphanet J Rare Dis | 2021 | 34294115 | PubTator, text mining | PubMed |
| The H3.3K27M oncohistone antagonizes reprogramming in Drosophila. | PLoS Genet | 2021 | 34280185 | PubTator, text mining | PubMed |
| SOHO State of the Art Updates and Next Questions: Identifying and Treating "Progression" in Myelofibrosis. | Clin Lymphoma Myeloma Leuk | 2021 | 34272171 | PubTator, text mining | PubMed |
| Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human. | Stem Cell Res Ther | 2021 | 34266496 | PubTator, text mining | PubMed |
| Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas. | Sci Rep | 2021 | 34257334 | PubTator, text mining | PubMed |
| Therapeutic Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Female Reproductive Diseases. | Front Endocrinol (Lausanne) | 2021 | 34248842 | PubTator, text mining | PubMed |
| High-throughput measurements of bone morphogenetic protein/bone morphogenetic protein receptor interactions using biolayer interferometry. | Biointerphases | 2021 | 34241280 | PubTator, text mining | PubMed |
| The Role of BMP Signaling in Endothelial Heterogeneity. | Front Cell Dev Biol | 2021 | 34235147 | PubTator, text mining | PubMed |
| Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRT. | Front Oncol | 2021 | 34221967 | PubTator, text mining | PubMed |
| Activation of the DDR Pathway Leads to the Down-Regulation of the TGFβ Pathway and a Better Response to ICIs in Patients With Metastatic Urothelial Carcinoma. | Front Immunol | 2021 | 34220801 | PubTator, text mining | PubMed |
| Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma. | Nat Commun | 2021 | 34215733 | PubTator, text mining | PubMed |
| Origins, potency, and heterogeneity of skeletal muscle fibro-adipogenic progenitors-time for new definitions. | Skelet Muscle | 2021 | 34210364 | PubTator, text mining | PubMed |
| Bioactive Lipid O-cyclic phytosphingosine-1-phosphate Promotes Differentiation of Human Embryonic Stem Cells into Cardiomyocytes via ALK3/BMPR Signaling. | Int J Mol Sci | 2021 | 34209900 | PubTator, text mining | PubMed |
| Personalized Genetic Diagnosis of Congenital Heart Defects in Newborns. | J Pers Med | 2021 | 34208491 | PubTator, text mining | PubMed |
| The Peculiar Trialogue between Pediatric Obesity, Systemic Inflammatory Status, and Immunity. | Biology (Basel) | 2021 | 34207683 | PubTator, text mining | PubMed |
| Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders. | Biomedicines | 2021 | 34206903 | PubTator, text mining | PubMed |
| Activin-A Induces Early Differential Gene Expression Exclusively in Periodontal Ligament Fibroblasts from Fibrodysplasia Ossificans Progressiva Patients. | Biomedicines | 2021 | 34205844 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=45